Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Efficacy and Safety Trial with Oral S 44819 after Recent Ischemic Cerebral Event
2016-001005-16Phase 2Completed
- Sponsor
- Servier
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of S44819 in ischemic stroke and stroke (3 arms), sponsored by Servier. Primary endpoint: Modified Rankin Scale (mRS) after 90 days of treatment. Started Jun 2016; status: completed.
02
Drugs
S44819
03
Conditions
ischemic strokestroke
Beyond the preview
Go deeper on 2016-001005-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001005-16.